Each receptor contributes distinct effects: GLP-1 Receptor Component Glucose-dependent insulin secretion from pancreatic beta cells Glucagon suppression in pancreatic alpha cells Slowed gastric emptying Hypothalamic appetite reduction GIP Receptor Component Additional insulin secretion enhancement (synergistic with GLP-1) Direct adipose tissue effects on lipid metabolism Centrally mediated appetite effects via brain GIP receptors Glucagon Receptor Component (Unique to Retatrutide) Increased energy expenditure glucagon receptor activity raises metabolic rate Hepatic glucose output modulation increases glucose production in liver (counterbalanced by GLP-1s insulin effects) Direct fatty acid oxidation effects in liver and muscle tissue Body composition effects from energy expenditure changes The glucagon receptor component is what makes retatrutide unique
( F ) Myography readings depicting vasorelaxation of ex vivo mesenteric arteries, assessed after phenylephrine preconstriction (1 M), in response to semaglutide (101,000 nM)
Non-Prescription and Natural Peptides BPC-157 is a tissue-repair peptide that supports digestive function, gut health, and recovery from exercise, and its role in weight loss is framed as indirect: better healing and inflammation control are described as supporting the broader weight loss process rather than driving fat loss on their own
Medical decisions about prescription treatments are appropriately made through consultation with qualified clinicians
Secondly, in some cases, GI issues with Ozempic can make it harder to absorb key hair-healthy nutrients like iron, zinc, and protein from food
